CAHR’s Market Access 101: Fundamentals of Reimbursement in Canada
We will explore the market access decision-making pathway for pharmaceuticals from Health Canada approval through reimbursement in private and public drug plans. Attendees will gain insights into the various steps and the inter-relationships between each milestone of pharmaceutical market access. The sessions will also address the interests and involvement of various perspectives, including public payers, private payers and patients.
We will also be focusing on networking and market access careers discussions during a lunch-hour workshop that will get you actively engaged with colleagues and speakers.
Anyone who wants to learn more about market access should consider joining us, and if you are seeking your Market Access Certification through our CMAP program this is a must-attend event!
ROOM IB 140, University of Toronto Mississauga Campus
3359 Mississauga Rd, Mississauga, ON L5L 1C6
- 2018 PDA Biosimilars Workshop
- Sep 26 2018 - Sep 27 2018
- All of the day